Dabigatran in Patients With Nonvalvular Atrial Fibrillation

被引：3
|
作者：
Gage, Lawrence [1 ]
机构：
[1] Rochester Gen Hosp, Rochester Cardiopulm Grp, PC, Rochester, NY 14621 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2011年 / 58卷 / 05期
关键词：
D O I：
10.1016/j.jacc.2011.04.016
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [41] Warfarin or Dabigatran in patients with atrial fibrillation
    Meinertz, T.
    Nitschmann, S.
    INTERNIST, 2011, 52 (04): : 462 - +
  • [42] A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillation
    Meixiang Yu
    Zi Wang
    Liuliu Zong
    Qing Xu
    Xiaoye Li
    Qianzhou Lv
    International Journal of Clinical Pharmacy, 2022, 44 : 1149 - 1157
  • [43] Prevention of stroke in patients with nonvalvular atrial fibrillation
    Hart, RG
    Sherman, DG
    Easton, JD
    Cairns, JA
    NEUROLOGY, 1998, 51 (03) : 674 - 681
  • [44] Types of atrial fibrillation and one year outcomes in patients with nonvalvular atrial fibrillation
    Tian, Li
    Zhu, Jun
    Zhang, Han
    Shao, Xinghui
    Liang, Yan
    Li, Jiandong
    Yang, Yanmin
    CARDIOLOGY, 2013, 126 : 4 - 4
  • [45] Dabigatran versus Warfarin on Cognitive Outcomes in Nonvalvular Atrial Fibrillation: Results of the GIRAF Trial
    Caramelli, Bruno
    Yu, Pai C.
    Cardozo, Francisco A.
    Magalhaes, Iuri R.
    Feitosa, Raul R.
    Spera, Raphael
    Amado, Daniel
    Escalante Rojas, Maria Carmen
    Gualandro, Danielle M.
    Calderaro, Daniela
    Tavares, Caio de Assis Moura A.
    Borges-Junior, Flavio A.
    Pastana, Adriana F.
    Gomes Matheus, Mariana G.
    Brucki, Sonia M.
    Rodrigues, Ana C.
    Nitrini, Ricardo M.
    Caramelli, Paulo
    CIRCULATION, 2021, 144 (25) : E569 - E569
  • [46] Association Between the Change in Total Bilirubin and Risk of Bleeding Among Patients With Nonvalvular Atrial Fibrillation Taking Dabigatran
    Xiong, Yurong
    Hu, Lihua
    Zhou, Wei
    Li, Minghui
    Wang, Tao
    Huang, Xiao
    Bao, Huihui
    Cheng, Xiaoshu
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2020, 26
  • [47] EVALUATION OF HEALTHCARE COSTS OF ELDERLY NONVALVULAR ATRIAL FIBRILLATION PATIENTS TREATED WITH APIXABAN VS. RIVAROXABAN AND DABIGATRAN
    Deitelzweig, S.
    Luo, X.
    Gupta, K.
    Trocio, J.
    Mardekian, J.
    Curtice, T.
    Lingohr-Smith, M.
    Menges, B. L.
    Lin, J.
    VALUE IN HEALTH, 2017, 20 (05) : A266 - A266
  • [48] Cost-Utility Analysis of Dabigatran and Warfarin for Stroke Prevention Among Patients With Nonvalvular Atrial Fibrillation in India
    Aghoram, Rajeswari
    Kumar, S. Mathan
    Rajasulochana, Subramania Raju
    Kar, Sitanshu Sekhar
    Aggarwal, Rakesh
    VALUE IN HEALTH REGIONAL ISSUES, 2022, 31 : 119 - 126
  • [49] A novel coagulation parameter monitoring bleeding tendency of Chinese nonvalvular atrial fibrillation patients prescribing dabigatran etexilate
    Wang, Hong
    Zhou, Yun
    Rong, Guodong
    Lu, Lin
    Zhang, Jie
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (05) : 563 - 567
  • [50] Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
    Silva, Vanessa M.
    Scanavacca, Mauricio
    Darrieux, Francisco
    Cavalheiro, Cyrillo
    Strunz, Celia C.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
12345